Journal article
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
- Abstract:
-
BACKGROUND: Based on a large, representative unscreened cohort from Malmö, Sweden, we have recently reported that a single prostate-specific antigen (PSA) measurement at or before age 50 is a strong predictor of prostate cancer occurring up to 25 years subsequently. We aimed to determine whether this association holds for advanced cancers, defined as clinical stage T3 or higher, or skeletal metastasis at the time of the cancer diagnosis. METHODS: In 1974-1986 blood samples were obtained from...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 269.9KB)
-
- Publisher copy:
- 10.1186/1741-7015-6-6
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Funding
+ National Cancer Institute
More from this funder
Funding agency for:
Lilja, H
Grant:
LSHC-CT-2004-503011
+ Swedish Cancer Society
More from this funder
Funding agency for:
Lilja, H
Grant:
LSHC-CT-2004-503011
+ European Commission's Sixth Framework Programme
More from this funder
Funding agency for:
Lilja, H
Grant:
LSHC-CT-2004-503011
+ Fundacion Federico SA
More from this funder
Funding agency for:
Lilja, H
Grant:
LSHC-CT-2004-503011
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC medicine Journal website
- Volume:
- 6
- Issue:
- 1
- Pages:
- Article no. 6
- Publication date:
- 2008-01-01
- DOI:
- EISSN:
-
1741-7015
- ISSN:
-
1741-7015
- Source identifiers:
-
365935
Item Description
- Language:
- English
- Keywords:
- UUID:
-
uuid:3a3f0e77-1291-43a5-97a1-3c70f4ed63af
- Local pid:
- pubs:365935
- Deposit date:
- 2013-11-16
Terms of use
- Copyright holder:
- Ulmert et al
- Copyright date:
- 2008
- Notes:
- Copyright 2008 Ulmert et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record